article thumbnail

BioUtah Announces Headline Speakers for the 2020 Virtual Utah Life Sciences Summit

BioTech 365

Jeffrey Shuren, MD, JD, director of the Center for Devices and Radiological Health (CDHR) at the Food and Drug Administration (FDA), and Dr. Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at the … Continue reading →

article thumbnail

Genomics England will move HQ to Canary Wharf’s new biocluster

pharmaphorum

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development. facility dedicated to a combination of wet lab and office space, revealed in March, intended as a focal point for life sciences companies in London.

Genome 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.

article thumbnail

Magnus Medical’s SAINT Neuromodulation System Gets FDA Clearance to Treat MDD

XTalks

Related: Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression – Xtalks Life Science Podcast Ep. The SAINT Neuromodulation Trial. The older approaches often took six weeks for depression to respond, while this approach observed remission from depression in just five days,” said Mark S.

article thumbnail

Four ways Biogen is tackling digital innovation in neurological disease

pharmaphorum

It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. About half of our talents come from the life sciences industry and clinical research, and the other half come from the tech world – so, totally different backgrounds,” Hadjiat said. “We

article thumbnail

Bayer’s Gadovist™ (Gadobutrol) at a Reduced Dose Demonstrates Non-Inferiority Compared to a Standard Dose of Gadoterate for CNS Imaging

The Pharma Data

Dr. Olaf Weber, Head of Radiology Research and Development at Bayer. About Radiology at Bayer Everyone deserves clear answers about their health, starting with an early and accurate diagnosis. Currently, the quality dose for all marketed GBCAs, including gadobutrol and gadoterate, is 0.1 mmol/kg weight. “At

article thumbnail

Unique ADHD Biomarkers Revealed from MRI Data from the Adolescent Brain Cognitive Development Study

XTalks

The study results will be presented at the Radiological Society of North America annual meeting , which is currently being held in Chicago, IL until December 1, 2022. These ADHD biomarkers could help clinicians diagnose, treat and track symptoms in children. What is ADHD and How is it Diagnosed?